Citadel Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Citadel Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,900	Closed	-$259K	–	14839
2022 Q1	$259K	Sell	13,900 -15,500	-53%	-$279K	﹤0.01%	10927
2021 Q4	$629K	Sell	29,400 -13,400	-31%	-$264K	﹤0.01%	9111
2021 Q3	$791K	Sell	42,800 -156,600	-79%	-$3.15M	﹤0.01%	8734
2021 Q2	$4.27M	Buy	199,400 +20,100	+11%	+$409K	﹤0.01%	4784
2021 Q1	$3.46M	Buy	+179,300	New	+$3.16M	﹤0.01%	5094

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's OCDX Position: Q2 2022 in Review

Citadel Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 245,555 shares — an estimated $4.58M sold.

Citadel Advisors first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $4.58M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Citadel Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Citadel Advisors sold 245,555 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $4.58M.
Citadel Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Citadel Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4.58M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.